Medically reviewed by Jeffrey S. Lander, MD Key Takeaways A low red blood cell count can be the result of lifestyle factors ...
Ibrutinib normalizes RBC aggregation in CLL, potentially reducing thrombotic risks by mitigating blood flow complications. Obinutuzumab/venetoclax combination does ...